Search Results 101-110 of 18085 for Parkinson's disease
Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter Springer, Ph.D., studies the relevance of PINK1- and PRKN ...
Learn about available training opportunities in Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic's campus in Florida.
Cytoplasmic deposition of alpha-synuclein aggregates is a common pathological feature of many neurodegenerative synucleinopathies, including Parkinson's disease ...
See research collaborators of Mayo Clinic's Parkinson's Disease Lab led by Owen A. Ross, Ph.D.
Evidence suggests NLY01, a pegylated form of exenatide, may be beneficial in PD and is being developed as a potential treatment for neurodegenerative disorders.
Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter Springer, Ph.D., is identifying novel mitophagy regulators and ...
Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab uses computational structural modeling to understand PINK1 and Parkin variants.
Contact Dr. McLean about her Parkinson's disease research at Mayo Clinic's Neurobiology of Parkinson's Disease Lab in Florida.
Read news highlighting gene studies in Parkinson's disease from Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter ...
... and Monitoring of Disease Progression of Parkinson's Disease and REM Sleep Behavior Disorder ... diagnosed subjects with Parkinson's disease (PD) and 20 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.